Leukemia publishes preclinical development results of CAR-T therapy GYA01 for acute myeloid leukemia (AML) and T-cell acute lymphoblastic leukemia (T-ALL)
LANCASTER, S.C., Sept. 15, 2025 /PRNewswire/ -- Get ready for another unforgettable year of A Different Way to CE™! Since
The company is focusing on its European operations. EY advised Statkraft, and Standard Chartered advised Serentica.
The company is collaborating with technology providers and state governments to explore individual nuclear projects, Singh has said.
The Offshore Support Vessel Market size was valued at over USD 22.5 Bn in 2024 and is expected to grow